Your browser doesn't support javascript.
loading
Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions.
Cilli, Aykut; Ocal, Nesrin; Uzer, Fatih; Coskun, Funda; Sevinc, Can; Ursavas, Ahmet; Yildiz, Pinar; Deniz, Pelin Pinar; Yilmaz Demirci, Nilgün; Ozbey, Gamze; Yurttas, Ahmet; Hanta, Ismail.
Afiliação
  • Cilli A; Department of Respiratory Disease, Akdeniz University, Antalya, Turkey. Electronic address: acilli@akdeniz.edu.tr.
  • Ocal N; Department of Respiratory Diseases, University of Health Sciences, Gulhane Faculty of Medicine, Ankara, Turkey.
  • Uzer F; Department of Respiratory Disease, Akdeniz University, Antalya, Turkey.
  • Coskun F; Department of Respiratory Disease, Uludag University, Bursa, Turkey.
  • Sevinc C; Department of Respiratory Disease, Dokuz Eylül University, Izmir, Turkey.
  • Ursavas A; Department of Respiratory Disease, Uludag University, Bursa, Turkey.
  • Yildiz P; Department of Respiratory Disease, SBU Yedikule Training and Research Hospital, Istanbul, Turkey.
  • Deniz PP; Department of Respiratory Disease, Cukurova University, Adana, Turkey.
  • Yilmaz Demirci N; Department of Respiratory Disease, Gazi University, Ankara, Turkey.
  • Ozbey G; Department of Respiratory Disease, Akdeniz University, Antalya, Turkey.
  • Yurttas A; Department of Respiratory Disease, Uludag University, Bursa, Turkey.
  • Hanta I; Department of Respiratory Disease, Cukurova University, Adana, Turkey.
Respir Investig ; 61(4): 490-497, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37245284

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Redução da Medicação Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Redução da Medicação Idioma: En Ano de publicação: 2023 Tipo de documento: Article